nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP19A1—Paclitaxel—ovarian cancer	0.159	0.378	CbGbCtD
Terbinafine—CYP2C8—Paclitaxel—ovarian cancer	0.0498	0.118	CbGbCtD
Terbinafine—CYP2D6—Vinorelbine—ovarian cancer	0.0452	0.107	CbGbCtD
Terbinafine—CYP3A4—Topotecan—ovarian cancer	0.0408	0.0968	CbGbCtD
Terbinafine—CYP19A1—follicular fluid—ovarian cancer	0.0373	0.178	CbGeAlD
Terbinafine—CYP2C9—Paclitaxel—ovarian cancer	0.0347	0.0824	CbGbCtD
Terbinafine—CYP11A1—corpus luteum—ovarian cancer	0.0331	0.158	CbGeAlD
Terbinafine—CYP3A4—Vinorelbine—ovarian cancer	0.0287	0.0682	CbGbCtD
Terbinafine—CYP11A1—ovarian follicle—ovarian cancer	0.0259	0.124	CbGeAlD
Terbinafine—CYP19A1—corpus luteum—ovarian cancer	0.0215	0.103	CbGeAlD
Terbinafine—CYP3A4—Paclitaxel—ovarian cancer	0.0202	0.0479	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—ovarian cancer	0.0171	0.0406	CbGbCtD
Terbinafine—CYP19A1—ovarian follicle—ovarian cancer	0.0168	0.0804	CbGeAlD
Terbinafine—CYP3A4—Docetaxel—ovarian cancer	0.0146	0.0346	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—ovarian cancer	0.0109	0.0258	CbGbCtD
Terbinafine—SQLE—uterine cervix—ovarian cancer	0.00432	0.0207	CbGeAlD
Terbinafine—PTGS1—oviduct—ovarian cancer	0.00429	0.0205	CbGeAlD
Terbinafine—SQLE—decidua—ovarian cancer	0.00412	0.0197	CbGeAlD
Terbinafine—SQLE—endometrium—ovarian cancer	0.00391	0.0187	CbGeAlD
Terbinafine—SQLE—gonad—ovarian cancer	0.00363	0.0173	CbGeAlD
Terbinafine—SQLE—uterus—ovarian cancer	0.0036	0.0172	CbGeAlD
Terbinafine—SQLE—female reproductive system—ovarian cancer	0.00324	0.0155	CbGeAlD
Terbinafine—SQLE—female gonad—ovarian cancer	0.00295	0.0141	CbGeAlD
Terbinafine—SQLE—vagina—ovarian cancer	0.00293	0.014	CbGeAlD
Terbinafine—CYP11A1—decidua—ovarian cancer	0.0027	0.0129	CbGeAlD
Terbinafine—SQLE—testis—ovarian cancer	0.00261	0.0125	CbGeAlD
Terbinafine—CYP11A1—gonad—ovarian cancer	0.00238	0.0114	CbGeAlD
Terbinafine—CYP11A1—female reproductive system—ovarian cancer	0.00212	0.0101	CbGeAlD
Terbinafine—CYP11A1—female gonad—ovarian cancer	0.00193	0.00923	CbGeAlD
Terbinafine—SQLE—lymph node—ovarian cancer	0.0019	0.00906	CbGeAlD
Terbinafine—CYP11A1—testis—ovarian cancer	0.00171	0.00819	CbGeAlD
Terbinafine—CYP19A1—endometrium—ovarian cancer	0.00167	0.00796	CbGeAlD
Terbinafine—CYP19A1—gonad—ovarian cancer	0.00154	0.00738	CbGeAlD
Terbinafine—CYP19A1—uterus—ovarian cancer	0.00153	0.00733	CbGeAlD
Terbinafine—CYP19A1—female reproductive system—ovarian cancer	0.00138	0.00659	CbGeAlD
Terbinafine—CYP19A1—female gonad—ovarian cancer	0.00126	0.006	CbGeAlD
Terbinafine—CYP11A1—lymph node—ovarian cancer	0.00124	0.00594	CbGeAlD
Terbinafine—CYP2C8—endometrium—ovarian cancer	0.00119	0.0057	CbGeAlD
Terbinafine—CYP19A1—testis—ovarian cancer	0.00111	0.00532	CbGeAlD
Terbinafine—PTGS1—epithelium—ovarian cancer	0.00108	0.00515	CbGeAlD
Terbinafine—PTGS1—uterine cervix—ovarian cancer	0.00107	0.00511	CbGeAlD
Terbinafine—CYP2C19—vagina—ovarian cancer	0.00102	0.00489	CbGeAlD
Terbinafine—CYP2C8—female reproductive system—ovarian cancer	0.000988	0.00472	CbGeAlD
Terbinafine—PTGS1—endometrium—ovarian cancer	0.000967	0.00462	CbGeAlD
Terbinafine—CYP2C8—vagina—ovarian cancer	0.000893	0.00427	CbGeAlD
Terbinafine—PTGS1—uterus—ovarian cancer	0.000891	0.00426	CbGeAlD
Terbinafine—CYP2C9—female reproductive system—ovarian cancer	0.000877	0.00419	CbGeAlD
Terbinafine—CYP19A1—lymph node—ovarian cancer	0.000807	0.00386	CbGeAlD
Terbinafine—PTGS1—female reproductive system—ovarian cancer	0.000801	0.00383	CbGeAlD
Terbinafine—CYP2C8—testis—ovarian cancer	0.000797	0.00381	CbGeAlD
Terbinafine—PTGS1—female gonad—ovarian cancer	0.000729	0.00348	CbGeAlD
Terbinafine—PTGS1—vagina—ovarian cancer	0.000724	0.00346	CbGeAlD
Terbinafine—CYP3A4—female reproductive system—ovarian cancer	0.000669	0.0032	CbGeAlD
Terbinafine—CYP2D6—female reproductive system—ovarian cancer	0.000658	0.00315	CbGeAlD
Terbinafine—PTGS1—testis—ovarian cancer	0.000646	0.00309	CbGeAlD
Terbinafine—CYP2D6—female gonad—ovarian cancer	0.000599	0.00286	CbGeAlD
Terbinafine—CYP2D6—testis—ovarian cancer	0.000531	0.00254	CbGeAlD
Terbinafine—PTGS1—lymph node—ovarian cancer	0.000469	0.00224	CbGeAlD
Terbinafine—Malaise—Paclitaxel—ovarian cancer	0.000355	0.00118	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000354	0.00118	CcSEcCtD
Terbinafine—Vertigo—Paclitaxel—ovarian cancer	0.000354	0.00118	CcSEcCtD
Terbinafine—Rash—Topotecan—ovarian cancer	0.000352	0.00117	CcSEcCtD
Terbinafine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000352	0.00117	CcSEcCtD
Terbinafine—Dermatitis—Topotecan—ovarian cancer	0.000352	0.00117	CcSEcCtD
Terbinafine—Headache—Topotecan—ovarian cancer	0.00035	0.00117	CcSEcCtD
Terbinafine—Angiopathy—Docetaxel—ovarian cancer	0.000348	0.00116	CcSEcCtD
Terbinafine—Vomiting—Melphalan—ovarian cancer	0.000348	0.00116	CcSEcCtD
Terbinafine—Immune system disorder—Docetaxel—ovarian cancer	0.000346	0.00115	CcSEcCtD
Terbinafine—Rash—Melphalan—ovarian cancer	0.000345	0.00115	CcSEcCtD
Terbinafine—Dermatitis—Melphalan—ovarian cancer	0.000344	0.00115	CcSEcCtD
Terbinafine—Cough—Paclitaxel—ovarian cancer	0.000344	0.00114	CcSEcCtD
Terbinafine—Asthenia—Vinorelbine—ovarian cancer	0.000343	0.00114	CcSEcCtD
Terbinafine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000341	0.00114	CcSEcCtD
Terbinafine—Alopecia—Docetaxel—ovarian cancer	0.000339	0.00113	CcSEcCtD
Terbinafine—Pruritus—Vinorelbine—ovarian cancer	0.000338	0.00113	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000337	0.00112	CcSEcCtD
Terbinafine—Mental disorder—Docetaxel—ovarian cancer	0.000336	0.00112	CcSEcCtD
Terbinafine—Arthralgia—Paclitaxel—ovarian cancer	0.000335	0.00112	CcSEcCtD
Terbinafine—Myalgia—Paclitaxel—ovarian cancer	0.000335	0.00112	CcSEcCtD
Terbinafine—Chest pain—Paclitaxel—ovarian cancer	0.000335	0.00112	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000334	0.00111	CcSEcCtD
Terbinafine—Anxiety—Paclitaxel—ovarian cancer	0.000334	0.00111	CcSEcCtD
Terbinafine—Erythema—Docetaxel—ovarian cancer	0.000334	0.00111	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000333	0.00111	CcSEcCtD
Terbinafine—Nausea—Topotecan—ovarian cancer	0.000332	0.00111	CcSEcCtD
Terbinafine—Discomfort—Paclitaxel—ovarian cancer	0.000331	0.0011	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—ovarian cancer	0.000331	0.0011	CcSEcCtD
Terbinafine—Dry mouth—Paclitaxel—ovarian cancer	0.000328	0.00109	CcSEcCtD
Terbinafine—Diarrhoea—Vinorelbine—ovarian cancer	0.000327	0.00109	CcSEcCtD
Terbinafine—Dysgeusia—Docetaxel—ovarian cancer	0.000327	0.00109	CcSEcCtD
Terbinafine—Nausea—Melphalan—ovarian cancer	0.000325	0.00108	CcSEcCtD
Terbinafine—Confusional state—Paclitaxel—ovarian cancer	0.000324	0.00108	CcSEcCtD
Terbinafine—Influenza—Epirubicin—ovarian cancer	0.000323	0.00108	CcSEcCtD
Terbinafine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000321	0.00107	CcSEcCtD
Terbinafine—Muscle spasms—Docetaxel—ovarian cancer	0.000321	0.00107	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—ovarian cancer	0.00032	0.00107	CcSEcCtD
Terbinafine—Infection—Paclitaxel—ovarian cancer	0.000319	0.00106	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—ovarian cancer	0.000317	0.00106	CcSEcCtD
Terbinafine—Dizziness—Vinorelbine—ovarian cancer	0.000316	0.00105	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000316	0.00105	CcSEcCtD
Terbinafine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000315	0.00105	CcSEcCtD
Terbinafine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000315	0.00105	CcSEcCtD
Terbinafine—Skin disorder—Paclitaxel—ovarian cancer	0.000312	0.00104	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000311	0.00104	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000309	0.00103	CcSEcCtD
Terbinafine—Anaemia—Docetaxel—ovarian cancer	0.000308	0.00103	CcSEcCtD
Terbinafine—Pancytopenia—Epirubicin—ovarian cancer	0.000307	0.00102	CcSEcCtD
Terbinafine—Anorexia—Paclitaxel—ovarian cancer	0.000306	0.00102	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—ovarian cancer	0.000306	0.00102	CcSEcCtD
Terbinafine—Vomiting—Vinorelbine—ovarian cancer	0.000304	0.00101	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—ovarian cancer	0.000302	0.00101	CcSEcCtD
Terbinafine—Rash—Vinorelbine—ovarian cancer	0.000301	0.001	CcSEcCtD
Terbinafine—Dermatitis—Vinorelbine—ovarian cancer	0.000301	0.001	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.0003	0.001	CcSEcCtD
Terbinafine—Headache—Vinorelbine—ovarian cancer	0.000299	0.000997	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—ovarian cancer	0.000299	0.000996	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—ovarian cancer	0.000296	0.000986	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000295	0.000983	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—ovarian cancer	0.000293	0.000977	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000293	0.000976	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—ovarian cancer	0.000292	0.000974	CcSEcCtD
Terbinafine—Cough—Docetaxel—ovarian cancer	0.000291	0.00097	CcSEcCtD
Terbinafine—Paraesthesia—Paclitaxel—ovarian cancer	0.000288	0.000961	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—ovarian cancer	0.000288	0.00096	CcSEcCtD
Terbinafine—Infestation—Epirubicin—ovarian cancer	0.000288	0.00096	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000286	0.000952	CcSEcCtD
Terbinafine—Chest pain—Docetaxel—ovarian cancer	0.000284	0.000947	CcSEcCtD
Terbinafine—Myalgia—Docetaxel—ovarian cancer	0.000284	0.000947	CcSEcCtD
Terbinafine—Arthralgia—Docetaxel—ovarian cancer	0.000284	0.000947	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—ovarian cancer	0.000284	0.000946	CcSEcCtD
Terbinafine—Nausea—Vinorelbine—ovarian cancer	0.000284	0.000946	CcSEcCtD
Terbinafine—Dyspepsia—Paclitaxel—ovarian cancer	0.000283	0.000943	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000282	0.00094	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—ovarian cancer	0.000281	0.000936	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—ovarian cancer	0.000279	0.000931	CcSEcCtD
Terbinafine—Decreased appetite—Paclitaxel—ovarian cancer	0.000279	0.000931	CcSEcCtD
Terbinafine—Dry mouth—Docetaxel—ovarian cancer	0.000278	0.000926	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000278	0.000926	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000277	0.000924	CcSEcCtD
Terbinafine—Fatigue—Paclitaxel—ovarian cancer	0.000277	0.000923	CcSEcCtD
Terbinafine—Pain—Paclitaxel—ovarian cancer	0.000275	0.000916	CcSEcCtD
Terbinafine—Confusional state—Docetaxel—ovarian cancer	0.000275	0.000915	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000273	0.000909	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000272	0.000908	CcSEcCtD
Terbinafine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000272	0.000908	CcSEcCtD
Terbinafine—Infection—Docetaxel—ovarian cancer	0.000271	0.000902	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—ovarian cancer	0.00027	0.000901	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—ovarian cancer	0.000269	0.000896	CcSEcCtD
Terbinafine—Nervous system disorder—Docetaxel—ovarian cancer	0.000267	0.00089	CcSEcCtD
Terbinafine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000267	0.000889	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—ovarian cancer	0.000266	0.000888	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—ovarian cancer	0.000266	0.000888	CcSEcCtD
Terbinafine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000265	0.000882	CcSEcCtD
Terbinafine—Skin disorder—Docetaxel—ovarian cancer	0.000265	0.000882	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000264	0.00088	CcSEcCtD
Terbinafine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000263	0.000876	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—ovarian cancer	0.00026	0.000866	CcSEcCtD
Terbinafine—Anorexia—Docetaxel—ovarian cancer	0.00026	0.000865	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—ovarian cancer	0.000259	0.000862	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000257	0.000857	CcSEcCtD
Terbinafine—Urticaria—Paclitaxel—ovarian cancer	0.000255	0.000851	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000254	0.000847	CcSEcCtD
Terbinafine—Body temperature increased—Paclitaxel—ovarian cancer	0.000254	0.000846	CcSEcCtD
Terbinafine—Abdominal pain—Paclitaxel—ovarian cancer	0.000254	0.000846	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000252	0.00084	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—ovarian cancer	0.000249	0.00083	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000249	0.000829	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000248	0.000827	CcSEcCtD
Terbinafine—Paraesthesia—Docetaxel—ovarian cancer	0.000245	0.000815	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—ovarian cancer	0.000244	0.000815	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—ovarian cancer	0.000242	0.000805	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—ovarian cancer	0.000241	0.000803	CcSEcCtD
Terbinafine—Dyspepsia—Docetaxel—ovarian cancer	0.00024	0.000799	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—ovarian cancer	0.000239	0.000797	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000238	0.000793	CcSEcCtD
Terbinafine—Decreased appetite—Docetaxel—ovarian cancer	0.000237	0.000789	CcSEcCtD
Terbinafine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000237	0.000789	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000235	0.000784	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000235	0.000783	CcSEcCtD
Terbinafine—Fatigue—Docetaxel—ovarian cancer	0.000235	0.000782	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—ovarian cancer	0.000235	0.000782	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—ovarian cancer	0.000234	0.000778	CcSEcCtD
Terbinafine—Pain—Docetaxel—ovarian cancer	0.000233	0.000776	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—ovarian cancer	0.000231	0.000768	CcSEcCtD
Terbinafine—Asthenia—Paclitaxel—ovarian cancer	0.000231	0.000768	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—ovarian cancer	0.000228	0.000761	CcSEcCtD
Terbinafine—Pruritus—Paclitaxel—ovarian cancer	0.000227	0.000758	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—ovarian cancer	0.000226	0.000755	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000226	0.000754	CcSEcCtD
Terbinafine—Erythema—Epirubicin—ovarian cancer	0.000225	0.00075	CcSEcCtD
Terbinafine—Feeling abnormal—Docetaxel—ovarian cancer	0.000224	0.000748	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—ovarian cancer	0.000224	0.000745	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—ovarian cancer	0.000223	0.000743	CcSEcCtD
Terbinafine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000223	0.000742	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—ovarian cancer	0.000222	0.000739	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—ovarian cancer	0.00022	0.000735	CcSEcCtD
Terbinafine—Diarrhoea—Paclitaxel—ovarian cancer	0.00022	0.000733	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—ovarian cancer	0.000217	0.000723	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—ovarian cancer	0.000216	0.000721	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—ovarian cancer	0.000216	0.00072	CcSEcCtD
Terbinafine—Abdominal pain—Docetaxel—ovarian cancer	0.000215	0.000717	CcSEcCtD
Terbinafine—Body temperature increased—Docetaxel—ovarian cancer	0.000215	0.000717	CcSEcCtD
Terbinafine—Dizziness—Paclitaxel—ovarian cancer	0.000212	0.000708	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—ovarian cancer	0.000212	0.000707	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—ovarian cancer	0.000211	0.000704	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—ovarian cancer	0.00021	0.000698	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000209	0.000696	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—ovarian cancer	0.000208	0.000694	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—ovarian cancer	0.000208	0.000693	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—ovarian cancer	0.000205	0.000684	CcSEcCtD
Terbinafine—Vomiting—Paclitaxel—ovarian cancer	0.000204	0.000681	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—ovarian cancer	0.000204	0.00068	CcSEcCtD
Terbinafine—Malaise—Epirubicin—ovarian cancer	0.000203	0.000676	CcSEcCtD
Terbinafine—Rash—Paclitaxel—ovarian cancer	0.000203	0.000675	CcSEcCtD
Terbinafine—Dermatitis—Paclitaxel—ovarian cancer	0.000202	0.000675	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—ovarian cancer	0.000202	0.000674	CcSEcCtD
Terbinafine—Headache—Paclitaxel—ovarian cancer	0.000201	0.000671	CcSEcCtD
Terbinafine—Hypersensitivity—Docetaxel—ovarian cancer	0.000201	0.000669	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—ovarian cancer	0.0002	0.000667	CcSEcCtD
Terbinafine—Cough—Epirubicin—ovarian cancer	0.000196	0.000655	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—ovarian cancer	0.000196	0.000654	CcSEcCtD
Terbinafine—Asthenia—Docetaxel—ovarian cancer	0.000195	0.000651	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000193	0.000644	CcSEcCtD
Terbinafine—Pruritus—Docetaxel—ovarian cancer	0.000193	0.000642	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—ovarian cancer	0.000192	0.000641	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—ovarian cancer	0.000192	0.000639	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—ovarian cancer	0.000192	0.000639	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—ovarian cancer	0.000192	0.000639	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—ovarian cancer	0.000191	0.000636	CcSEcCtD
Terbinafine—Nausea—Paclitaxel—ovarian cancer	0.000191	0.000636	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00019	0.000634	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—ovarian cancer	0.000189	0.000631	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—ovarian cancer	0.000188	0.000626	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—ovarian cancer	0.000187	0.000625	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—ovarian cancer	0.000187	0.000624	CcSEcCtD
Terbinafine—Diarrhoea—Docetaxel—ovarian cancer	0.000186	0.000621	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—ovarian cancer	0.000185	0.000617	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000184	0.000612	CcSEcCtD
Terbinafine—Infection—Epirubicin—ovarian cancer	0.000182	0.000608	CcSEcCtD
Terbinafine—Cough—Doxorubicin—ovarian cancer	0.000182	0.000606	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—ovarian cancer	0.00018	0.0006	CcSEcCtD
Terbinafine—Dizziness—Docetaxel—ovarian cancer	0.00018	0.0006	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00018	0.000599	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—ovarian cancer	0.000178	0.000595	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—ovarian cancer	0.000177	0.000591	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—ovarian cancer	0.000177	0.000591	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—ovarian cancer	0.000177	0.000591	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—ovarian cancer	0.000177	0.000589	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000176	0.000587	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—ovarian cancer	0.000175	0.000584	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—ovarian cancer	0.000175	0.000584	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—ovarian cancer	0.000173	0.000578	CcSEcCtD
Terbinafine—Vomiting—Docetaxel—ovarian cancer	0.000173	0.000577	CcSEcCtD
Terbinafine—Rash—Docetaxel—ovarian cancer	0.000172	0.000572	CcSEcCtD
Terbinafine—Dermatitis—Docetaxel—ovarian cancer	0.000172	0.000572	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—ovarian cancer	0.000171	0.000571	CcSEcCtD
Terbinafine—Headache—Docetaxel—ovarian cancer	0.000171	0.000569	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00017	0.000566	CcSEcCtD
Terbinafine—Infection—Doxorubicin—ovarian cancer	0.000169	0.000563	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000167	0.000558	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000167	0.000555	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000166	0.000555	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—ovarian cancer	0.000165	0.00055	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—ovarian cancer	0.000165	0.00055	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—ovarian cancer	0.000162	0.00054	CcSEcCtD
Terbinafine—Nausea—Docetaxel—ovarian cancer	0.000162	0.000539	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—ovarian cancer	0.000162	0.000539	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—ovarian cancer	0.00016	0.000532	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000159	0.000528	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—ovarian cancer	0.000158	0.000528	CcSEcCtD
Terbinafine—Pain—Epirubicin—ovarian cancer	0.000157	0.000523	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000155	0.000516	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—ovarian cancer	0.000153	0.000509	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—ovarian cancer	0.000151	0.000504	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00015	0.000501	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—ovarian cancer	0.00015	0.000499	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—ovarian cancer	0.000148	0.000492	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000147	0.000489	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—ovarian cancer	0.000147	0.000488	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—ovarian cancer	0.000146	0.000486	CcSEcCtD
Terbinafine—Pain—Doxorubicin—ovarian cancer	0.000145	0.000484	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—ovarian cancer	0.000145	0.000484	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—ovarian cancer	0.000145	0.000484	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—ovarian cancer	0.00014	0.000467	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000139	0.000463	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—ovarian cancer	0.000135	0.000451	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—ovarian cancer	0.000135	0.00045	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—ovarian cancer	0.000134	0.000448	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—ovarian cancer	0.000134	0.000448	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—ovarian cancer	0.000132	0.000439	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—ovarian cancer	0.00013	0.000433	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—ovarian cancer	0.000126	0.000419	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000125	0.000417	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—ovarian cancer	0.000122	0.000406	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—ovarian cancer	0.000121	0.000405	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—ovarian cancer	0.00012	0.000401	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—ovarian cancer	0.000117	0.000389	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—ovarian cancer	0.000116	0.000388	CcSEcCtD
Terbinafine—Rash—Epirubicin—ovarian cancer	0.000116	0.000386	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—ovarian cancer	0.000116	0.000386	CcSEcCtD
Terbinafine—Headache—Epirubicin—ovarian cancer	0.000115	0.000383	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—ovarian cancer	0.000112	0.000375	CcSEcCtD
Terbinafine—Nausea—Epirubicin—ovarian cancer	0.000109	0.000364	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—ovarian cancer	0.000108	0.00036	CcSEcCtD
Terbinafine—Rash—Doxorubicin—ovarian cancer	0.000107	0.000357	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—ovarian cancer	0.000107	0.000357	CcSEcCtD
Terbinafine—Headache—Doxorubicin—ovarian cancer	0.000106	0.000355	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—ovarian cancer	0.000101	0.000336	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	6.83e-05	0.000985	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.8e-05	0.000981	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	6.75e-05	0.000973	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	6.7e-05	0.000966	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.69e-05	0.000965	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.63e-05	0.000956	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	6.61e-05	0.000953	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.58e-05	0.000949	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	6.42e-05	0.000926	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.29e-05	0.000907	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	6.28e-05	0.000906	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	6.28e-05	0.000906	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	6.28e-05	0.000906	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CG—ovarian cancer	6.28e-05	0.000905	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	6.26e-05	0.000903	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—YAP1—ovarian cancer	6.16e-05	0.000888	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	6.15e-05	0.000887	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	6.15e-05	0.000886	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	6.15e-05	0.000886	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.1e-05	0.000879	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPP1CC—ovarian cancer	6.08e-05	0.000877	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—BRIP1—ovarian cancer	6.08e-05	0.000877	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.04e-05	0.000872	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	5.93e-05	0.000856	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NME2—ovarian cancer	5.87e-05	0.000847	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYTB—ovarian cancer	5.86e-05	0.000845	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	5.81e-05	0.000837	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.73e-05	0.000826	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CD—ovarian cancer	5.52e-05	0.000796	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.36e-05	0.000773	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	5.27e-05	0.000761	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NME2—ovarian cancer	5.24e-05	0.000756	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	5.17e-05	0.000746	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.17e-05	0.000745	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPP1CC—ovarian cancer	5.12e-05	0.000738	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—BRIP1—ovarian cancer	5.12e-05	0.000738	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.1e-05	0.000735	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—FASN—ovarian cancer	5.02e-05	0.000724	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.98e-05	0.000718	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—SLC5A5—ovarian cancer	4.94e-05	0.000712	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	4.94e-05	0.000712	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NME2—ovarian cancer	4.82e-05	0.000695	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CB—ovarian cancer	4.81e-05	0.000693	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NME2—ovarian cancer	4.78e-05	0.000689	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—SLC2A1—ovarian cancer	4.77e-05	0.000688	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.67e-05	0.000674	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP1B1—ovarian cancer	4.57e-05	0.00066	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	4.45e-05	0.000642	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.45e-05	0.000641	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.43e-05	0.000639	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTEN—ovarian cancer	4.16e-05	0.000599	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NME2—ovarian cancer	4.08e-05	0.000589	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—YAP1—ovarian cancer	4.08e-05	0.000588	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.06e-05	0.000586	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPP2R1A—ovarian cancer	4.06e-05	0.000585	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.05e-05	0.000585	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.04e-05	0.000582	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.04e-05	0.000582	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYTB—ovarian cancer	3.78e-05	0.000546	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ABCB1—ovarian cancer	3.77e-05	0.000543	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.73e-05	0.000538	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—TYMS—ovarian cancer	3.7e-05	0.000533	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.7e-05	0.000533	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.62e-05	0.000523	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.55e-05	0.000512	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.46e-05	0.0005	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—YAP1—ovarian cancer	3.43e-05	0.000495	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.4e-05	0.00049	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYTB—ovarian cancer	3.38e-05	0.000487	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—FASN—ovarian cancer	3.33e-05	0.00048	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—BRIP1—ovarian cancer	3.31e-05	0.000477	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPP1CC—ovarian cancer	3.31e-05	0.000477	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.31e-05	0.000477	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.3e-05	0.000476	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—SLC5A5—ovarian cancer	3.27e-05	0.000472	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—SLC2A1—ovarian cancer	3.16e-05	0.000456	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NME2—ovarian cancer	3.15e-05	0.000455	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYTB—ovarian cancer	3.11e-05	0.000448	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.09e-05	0.000446	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYTB—ovarian cancer	3.08e-05	0.000444	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP1B1—ovarian cancer	3.03e-05	0.000437	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.01e-05	0.000434	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.99e-05	0.000431	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CAV1—ovarian cancer	2.98e-05	0.00043	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.95e-05	0.000426	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.95e-05	0.000426	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CA—ovarian cancer	2.93e-05	0.000423	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.85e-05	0.000411	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.82e-05	0.000407	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—FASN—ovarian cancer	2.8e-05	0.000404	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—SLC5A5—ovarian cancer	2.75e-05	0.000397	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	2.72e-05	0.000392	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—BRIP1—ovarian cancer	2.72e-05	0.000392	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CG—ovarian cancer	2.71e-05	0.000392	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.69e-05	0.000388	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.69e-05	0.000388	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	2.69e-05	0.000387	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.67e-05	0.000386	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—SLC2A1—ovarian cancer	2.66e-05	0.000384	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYTB—ovarian cancer	2.63e-05	0.00038	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.6e-05	0.000376	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.57e-05	0.000371	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.55e-05	0.000368	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ABCB1—ovarian cancer	2.49e-05	0.00036	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—TYMS—ovarian cancer	2.45e-05	0.000353	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.41e-05	0.000348	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—AKT1—ovarian cancer	2.39e-05	0.000345	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CD—ovarian cancer	2.39e-05	0.000344	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—BRIP1—ovarian cancer	2.3e-05	0.000332	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	2.3e-05	0.000332	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPP2R1A—ovarian cancer	2.26e-05	0.000326	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.25e-05	0.000325	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—YAP1—ovarian cancer	2.22e-05	0.00032	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.2e-05	0.000317	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.15e-05	0.00031	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ABCB1—ovarian cancer	2.1e-05	0.000303	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CB—ovarian cancer	2.08e-05	0.0003	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—TYMS—ovarian cancer	2.06e-05	0.000297	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYTB—ovarian cancer	2.03e-05	0.000293	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—YAP1—ovarian cancer	1.98e-05	0.000286	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CAV1—ovarian cancer	1.97e-05	0.000285	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.96e-05	0.000283	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.96e-05	0.000283	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.93e-05	0.000278	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.89e-05	0.000272	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—YAP1—ovarian cancer	1.82e-05	0.000263	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—FASN—ovarian cancer	1.81e-05	0.000261	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—YAP1—ovarian cancer	1.81e-05	0.00026	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CG—ovarian cancer	1.8e-05	0.000259	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTEN—ovarian cancer	1.8e-05	0.000259	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.79e-05	0.000258	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.78e-05	0.000257	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.78e-05	0.000256	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.78e-05	0.000256	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.72e-05	0.000248	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.72e-05	0.000248	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.68e-05	0.000243	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.68e-05	0.000242	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CAV1—ovarian cancer	1.66e-05	0.00024	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.65e-05	0.000238	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—FASN—ovarian cancer	1.61e-05	0.000233	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.59e-05	0.000229	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.59e-05	0.000229	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CD—ovarian cancer	1.58e-05	0.000228	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.57e-05	0.000227	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—YAP1—ovarian cancer	1.54e-05	0.000223	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.53e-05	0.000221	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.53e-05	0.00022	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.51e-05	0.000218	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.5e-05	0.000217	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—FASN—ovarian cancer	1.48e-05	0.000214	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—FASN—ovarian cancer	1.47e-05	0.000212	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.47e-05	0.000212	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.46e-05	0.000211	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.46e-05	0.000211	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.45e-05	0.00021	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.45e-05	0.000209	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.41e-05	0.000203	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.4e-05	0.000202	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CB—ovarian cancer	1.38e-05	0.000199	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.37e-05	0.000197	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.36e-05	0.000196	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.35e-05	0.000195	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.34e-05	0.000194	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.34e-05	0.000193	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMS—ovarian cancer	1.33e-05	0.000192	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.33e-05	0.000192	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.3e-05	0.000188	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.3e-05	0.000187	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—ovarian cancer	1.27e-05	0.000183	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—FASN—ovarian cancer	1.26e-05	0.000181	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.24e-05	0.000178	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.21e-05	0.000175	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	0.000173	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.19e-05	0.000172	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.19e-05	0.000172	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—ovarian cancer	1.19e-05	0.000172	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMS—ovarian cancer	1.19e-05	0.000171	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.19e-05	0.000171	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.18e-05	0.000171	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.17e-05	0.000169	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.16e-05	0.000167	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.15e-05	0.000165	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.11e-05	0.000161	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.1e-05	0.000159	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.09e-05	0.000158	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMS—ovarian cancer	1.08e-05	0.000156	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAV1—ovarian cancer	1.07e-05	0.000155	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—ovarian cancer	1.04e-05	0.000149	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.03e-05	0.000148	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.02e-05	0.000147	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.01e-05	0.000146	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—ovarian cancer	1e-05	0.000145	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	9.78e-06	0.000141	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—FASN—ovarian cancer	9.71e-06	0.00014	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAV1—ovarian cancer	9.58e-06	0.000138	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	9.55e-06	0.000138	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCB1—ovarian cancer	9.43e-06	0.000136	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMS—ovarian cancer	9.27e-06	0.000134	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.22e-06	0.000133	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.15e-06	0.000132	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	8.84e-06	0.000127	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAV1—ovarian cancer	8.81e-06	0.000127	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAV1—ovarian cancer	8.74e-06	0.000126	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	8.73e-06	0.000126	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	8.6e-06	0.000124	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—ovarian cancer	8.4e-06	0.000121	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.35e-06	0.00012	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	8.03e-06	0.000116	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	7.96e-06	0.000115	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	7.84e-06	0.000113	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	7.67e-06	0.000111	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	7.49e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAV1—ovarian cancer	7.47e-06	0.000108	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.28e-06	0.000105	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMS—ovarian cancer	7.15e-06	0.000103	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.13e-06	0.000103	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—ovarian cancer	7.07e-06	0.000102	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	7.06e-06	0.000102	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	7e-06	0.000101	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—ovarian cancer	6.86e-06	9.9e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	6.8e-06	9.81e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	6.69e-06	9.64e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—ovarian cancer	6.47e-06	9.34e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	6.15e-06	8.87e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	6.1e-06	8.79e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.98e-06	8.62e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—ovarian cancer	5.78e-06	8.33e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—ovarian cancer	5.78e-06	8.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAV1—ovarian cancer	5.76e-06	8.31e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—ovarian cancer	5.32e-06	7.66e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.27e-06	7.6e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.25e-06	7.57e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.21e-06	7.51e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.61e-06	6.65e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	4.57e-06	6.59e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—ovarian cancer	4.5e-06	6.49e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	4.08e-06	5.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.02e-06	5.8e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.75e-06	5.41e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—ovarian cancer	3.73e-06	5.38e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.72e-06	5.36e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—ovarian cancer	3.48e-06	5.01e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—ovarian cancer	3.33e-06	4.8e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.18e-06	4.58e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.06e-06	4.42e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.04e-06	4.38e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—ovarian cancer	2.59e-06	3.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.45e-06	3.54e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—ovarian cancer	2e-06	2.89e-05	CbGpPWpGaD
